AI helps Stanford scientists discover natural Ozempic without usual side effects (www.sciencedaily.com)

Stanford Medicine researchers have leveraged artificial intelligence to discover a naturally occurring molecule, named BRP, that potentially offers the weight-loss benefits of Ozempic without the common side effects such as nausea and muscle loss. Unlike semaglutide, which acts on various tissues, BRP specifically targets the hypothalamus, the brain region that regulates hunger and metabolism, offering a more precise solution for appetite control. The significance of this discovery lies in its potential to address obesity more effectively than existing treatments, which often come with unwanted side effects. Using a tailored AI algorithm called Peptide Predictor, the team identified BRP from thousands of human proteins, pinpointing peptides with the most promise for influencing appetite. Initial animal studies indicated that BRP could decrease food intake by up to 50% without notable side effects, paving the way for future human clinical trials. The research highlights AI's growing role in biomedical advancements, particularly in the quest for safer obesity treatments.